Action AVCN AVICANNA INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Avicanna Inc.

Actions

AVCN

CA05368K1003

Marché Fermé - Toronto S.E.
Autres places de cotation
 21:59:59 15/07/2024 		Varia. 5j. Varia. 1 janv.
0,49 CAD +1,03 % Graphique intraday de Avicanna Inc. +28,95 % +40,00 %
10/07 Transcript : Avicanna Inc. - Shareholder/Analyst Call
19/06 Avicanna annonce la délivrance par l'Office américain des brevets et des marques d'un brevet sur la technologie SEDDS CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Avicanna Completes Commercial Export of Aureus Branded CBG Into Singapore
Avicanna Brief: Subsidiary Completed Export of Aureus Branded CBG into Singapore
Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore
Avicanna Announces Results of Annual General Meeting & Provides Corporate Update
Avicanna General Meeting
US Patent and Trademark Office Issues Patent For Avicanna's SEDDS Technology
Avicanna Brief: Announcing USPTO Issuance of Patent SEDDS Technology
Avicanna Announces USPTO Issuance of Patent SEDDS Technology
Avicanna Announces United States Patent and Trademark Office Issuance of Patent SEDDS Technology
Avicanna to Present at the Life Science Investor Forum June 20th, 2024
Avicanna Up 4.5% as it Books Record Q1 Revenue, First Adjusted EBITDA Positive Quarter in Company History
Avicanna Books Record Q1 Revenue, First Adjusted Ebitda Positive Quarter in Company History
Avicanna Brief: Record Q1 revenue of $6.45 million representing a year-over-year increase of 451% compared to Q1 2023
Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Avicanna Announced Results of Study in Patients with Epidermolysis Bullosa
Avicanna Brief: Announcing Results of Study in Patients with Epidermolysis Bullosa
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Avicanna Inc. Announces Results of Study in Patients with Epidermolysis Bullosa
Avicanna Raises About $2.1 Million in Non-brokered Private Placement
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action AVCN
  4. Actualités Avicanna Inc.
  5. Autres langues